Fig. 3From: Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancerComparison of somatic mutation frequency in inflammatory breast cancer (IBC) and non-IBC grouped by biological pathways. Data show the percentage of samples with alterations on 10 biological pathways; the gray bars indicate non-IBC, the black bars indicate IBC; *p < 0.05, **p < 0.01, ***p < 0.001Back to article page